title: [The epidemiological analysis of monitoring of the immune status in liquidators of consequences of the Chernobyl accident for early identification of risk groups and diagnostics of oncological diseases. Report 1].
abstract: Ionizing radiation is one of major factors of risk of oncological diseases. A question about the frequency of malignant neoplasms (MN) and their early identification in the liquidators of consequences of the Chernobyl accident remains opened. In the present work, the results of long-term immunological monitoring of the liquidators of consequences of the failure at the Chernobyl Nuclear Power Plant (ChN PP) living in the Northwest region of Russia are analyzed; we also heve made an attempt to reveal the predictors of oncological diseases in this group of individuals. The frequency of the newly revealed MN cases in a cohort of the persons who took part in liquidation of consequences of the ChNPP failure and were followed-up in 1999-2009, has made up 89 cases per 1005 persons (8.856%), which somewhat exceeds general population indicators. Regarding the frequency of separate MN localizations, lung cancer, cancer of stomach and cancer of prostate gland predominated, which corresponds to the world's tendency of MN prevalence. It has been established that as early as 1-3 years before diagnosis of MN is confirmed in liquidators, a number of changes in the immune status comes to light: drop in percentage of CD3+ and CD4(+)-T-lymphocytes, B-lymphocytes to a lesser extent, decrease in the CD4+/CD8+ index, increase of the relative and absolute content of CD16(+)-lymphocytes, increase of absolute content of CD8(+)-T-lymphocytes, prevalence of CD3+16/56+(NK-T) cell over CD3-16/56+(NK) cells, rise of the activity of phagocytes. Patients with the presence of one or several of the above-mentioned signs should be attributed to the MN risk group for determination of tumor markers, thorough examination and dynamic observation.
authors.forename: I V
authors.initials: IV
authors.lastname: Oradovskaia
authors.forename: Iu G
authors.initials: IuG
authors.lastname: Pashchenkova
authors.forename: V V
authors.initials: VV
authors.lastname: Feoktistov
authors.forename: M F
authors.initials: MF
authors.lastname: Nikonova
authors.forename: G Kh
authors.initials: GKh
authors.lastname: Vikulov
authors.forename: N V
authors.initials: NV
authors.lastname: Bozheskaia
authors.forename: N N
authors.initials: NN
authors.lastname: Smirnova
mesh_terms: D000328:Adult; D000368:Aged; D047852:Chernobyl Nuclear Accident; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D055633:Immune System Phenomena / Q000528:radiation effects*; D008297:Male; D008875:Middle Aged; D015166:Monitoring, Immunologic; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D009784:Occupational Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D016273:Occupational Exposure / Q000009:adverse effects*; D015995:Prevalence; D011379:Prognosis; D012306:Risk; D014455:Ukraine